Sarepta Therapeutics, Inc. SRPT Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProfitLoss.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s net income?
- Sarepta Therapeutics, Inc. (SRPT) reported net income of $330.96M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s net income changed year-over-year?
- Sarepta Therapeutics, Inc.'s net income increased by 174.0% year-over-year, from -$447.51M to $330.96M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s net income?
- Over 3 years (2021 to 2024), Sarepta Therapeutics, Inc.'s net income has grown at a -17.5% compound annual growth rate (CAGR), from -$418.78M to $235.24M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.